These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1574013)

  • 1. Thromboxane/prostacyclin balance in type II diabetes: gliclazide effects.
    Fu ZZ; Yan T; Chen YJ; Sang JQ
    Metabolism; 1992 May; 41(5 Suppl 1):33-5. PubMed ID: 1574013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
    Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gliclazide on plasma lipids and pancreatic beta cell function in non-insulin-dependent diabetes mellitus.
    Chen KW; Juang JH; Huang HS; Lin JD; Huang BY; Huang MJ
    Changgeng Yi Xue Za Zhi; 1993 Dec; 16(4):246-50. PubMed ID: 8313208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliclazide in the treatment of obese non-insulin dependent diabetic patients.
    Seshiah V; Venkataraman S; Suresh K
    J Assoc Physicians India; 1993 Jun; 41(6):367-8. PubMed ID: 8005974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of testosterone on lipids and eicosanoids in cynomolgus monkeys.
    Weyrich AS; Rejeski WJ; Brubaker PH; Parks JS
    Med Sci Sports Exerc; 1992 Mar; 24(3):333-8. PubMed ID: 1549028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia].
    Jian J; Hao X; Deng C; Zhou H; Lin J
    Zhonghua Nei Ke Za Zhi; 1999 Aug; 38(8):517-9. PubMed ID: 11798687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study.
    Cathelineau G; de Champvallins M; Bouallouche A; Lesobre B
    Metabolism; 1997 Dec; 46(12 Suppl 1):31-4. PubMed ID: 9439556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemobiological properties of gliclazide.
    Ziegler O; Drouin P
    J Diabetes Complications; 1994; 8(4):235-9. PubMed ID: 7833500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.
    Palmer KJ; Brogden RN
    Drugs; 1993 Jul; 46(1):92-125. PubMed ID: 7691511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.
    Betteridge DJ; Vergès B
    Diabetologia; 2005 Dec; 48(12):2477-81. PubMed ID: 16283239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gliclazide: metabolic and vascular effects--a perspective.
    Alberti KG; Johnson AB; Taylor R
    Metabolism; 1992 May; 41(5 Suppl 1):40-5. PubMed ID: 1574015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid peroxides, prostacyclin, and thromboxane A2 in runners during acute exercise.
    Viinikka L; Vuori J; Ylikorkala O
    Med Sci Sports Exerc; 1984 Jun; 16(3):275-7. PubMed ID: 6379367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans.
    Ylikorkala O; Puolakka J; Viinikka L
    Am J Obstet Gynecol; 1982 Mar; 142(5):573-6. PubMed ID: 7036746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cytostatics on prostaglandin F2 alpha prostacyclin, and thromboxane in patients with gynecologic malignancies.
    Ylikorkala O; Kauppila A; Viinikka L
    Obstet Gynecol; 1981 Oct; 58(4):483-6. PubMed ID: 7024882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of cardiovascular disorders in streptozotocin-induced diabetes in rat. II. Correlation between lipid peroxides, thromboxane A2/prostacyclin, and platelet aggregation in different stages of diabetes.
    Somova L; Kamenov V; Doncheva M; Kirilov G; Vassileva M
    Acta Physiol Pharmacol Bulg; 1988; 14(3):57-62. PubMed ID: 3066112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients.
    Ogawa S; Takeuchi K; Sugimura K; Sato C; Fukuda M; Lee R; Ito S; Sato T
    Clin Exp Pharmacol Physiol; 1999; 26(5-6):461-4. PubMed ID: 10386239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The content of stable forms of prostacyclin I2 and thromboxane A2 in the blood plasma in diabetic angiopathies].
    Sergienko AA
    Probl Endokrinol (Mosk); 1991; 37(4):24-6. PubMed ID: 1788186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliclazide: the effects on lipids in type II diabetes.
    Delargy M; McGovern M; Johnson A; Tomkin GH
    Ir J Med Sci; 1985 Mar; 154(3):102-5. PubMed ID: 3997441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.